LIU Juan, CHEN Canming, XU Yang, ZHANG Wei, ZHANG Lei. Interaction between aromatic hydrocarbon receptor signaling pathway-related gene polymorphism and its mRNA in the development of endometriosis[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 1-5, 9. DOI: 10.7619/jcmp.201913001
Citation: LIU Juan, CHEN Canming, XU Yang, ZHANG Wei, ZHANG Lei. Interaction between aromatic hydrocarbon receptor signaling pathway-related gene polymorphism and its mRNA in the development of endometriosis[J]. Journal of Clinical Medicine in Practice, 2019, 23(13): 1-5, 9. DOI: 10.7619/jcmp.201913001

Interaction between aromatic hydrocarbon receptor signaling pathway-related gene polymorphism and its mRNA in the development of endometriosis

More Information
  • Received Date: March 15, 2019
  • Accepted Date: April 25, 2019
  • Available Online: February 23, 2021
  • Published Date: July 14, 2019
  •   Objective  To explore the interaction between aromatic hydrocarbon receptor (AhR) signaling pathway-related genes [AHR, AhR nuclear heterotopic protein (ARNT), cytochrome P450 1A1 (CYP1A1), AhR repressor protein (AhRR), glutathione S-transferase 1 (GSTP1), interleukin-1β (IL-1β)] polymorphism and messenger RNA (mRNA) in endometriosis pathogenesis (EMT).
      Methods  A total of 25 patients with endometriosis confirmed by surgery and pathology were selected as case group (n=25), and 25 non-EMT patients were selected as control group (n=25). Gene polymorphism were detected by Polymerase Chain Reaction-High Resolution Melt (PCR-HRM) method, and expressions of mRNA were detected by real-time quantitative PCR in both groups. The gene-gene interactions were analyzed based on the simple-case-study method.
      Results  The levels of AhR, GSTP1 and IL-1β mRNAs in case group were significantly higher than those in control group (P < 0.01). The level of ARNT mRNA in case group increased significantly when compared with that in control group (P < 0.05). The risk of EMT in patients with CYP1A1 rs4646903 CC mutation genotype was 7.5 times higher than patients with homozygous wild genotype TT (95%CI: 1.29 to 43.69), and there were no significant differences in frequencies of other genotypes between case group and control group (P>0.05). The synergistic role of mutated CYP1A1 6235 T/C and mutated ARNT 522 G/C gene increased the risk of endometriosis (OR=9.33, 95%CI: 1.47 to 59.48), and the risk of disease also increased when combined with mutated CYP1A1 6235 T/C and mutated GSTP1313 A/G gene (OR=13.50, 95%CI: 1.34 to 135.98). Moreover, combined with mutated AHR 1661 G/A and AHRR 565 C/G appeared to cause a significant increase in endometriosis (OR=13.50, 95%CI: 1.34 to 159.98). No interaction was found at other loci.
      Conclusion  Patients with CYP1A1 rs4646903 CC gene has a high risk in developing endometriosis. The combined mutated genotypes (CYP1A1 6235 T/C and ARNT 522 G/C, CYP1A1 6235 T/C and GSTP1313 A/G) might be related with susceptibility to endometriosis.
  • [1]
    李雷, 冷金花. 子宫内膜异位症相关生活质量的研究进展[J]. 中华医学杂志, 2017, 97(45): 3593-3596. doi: 10.3760/cma.j.issn.0376-2491.2017.45.017
    [2]
    Smarr M M, Kannan K, Buck Louis G M. Endocrine disrupting chemicals and endometriosis[J]. Fertil Steril, 2016, 106(4): 959-966. doi: 10.1016/j.fertnstert.2016.06.034
    [3]
    Porpora M G, Ingelido A M, di Domenico A, et al. Increased levels of polychlorobiphenyls in Italian women with endometriosis[J]. Chemosphere, 2006, 63(8): 1361-1367. doi: 10.1016/j.chemosphere.2005.09.022
    [4]
    De Felip E, Porpora M G, di Domenico A, et al. Dioxin-like compounds and endometriosis: a study on Italian and Belgian women of reproductive age[J]. Toxicol Lett, 2004, 150(2): 203-209. doi: 10.1016/j.toxlet.2004.01.008
    [5]
    Hoffman C S, Small C M, Blanck H M, et al. Endometriosis among women exposed to polybrominated biphenyls[J]. Ann Epidemiol, 2007, 17(7): 503-510. doi: 10.1016/j.annepidem.2006.11.005
    [6]
    Rier S E, Martin D C, Bowman R E, et al. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin[J]. Fundam Appl Toxicol, 1993, 21(4): 433-441. doi: 10.1006/faat.1993.1119
    [7]
    刘娟, 任慕兰. 二噁英对小鼠异位子宫内膜中IL-1β表达的影响[J]. 中国妇幼健康研究, 2011, 22(2): 162-164. doi: 10.3969/j.issn.1673-5293.2011.02.015
    [8]
    Wen X, Xiong Y, Qu X L, et al. The risk of endometriosis after exposure to endocrine-disrupting chemicals: a meta-analysis of 30 epidemiology studies[J]. Gynecol Endocrinol, 2019: 1-6. doi: 10.1080/09513590.2019.1590546
    [9]
    陈苏, 周子寒, 阳晓敏, 等. 环境内分泌干扰物暴露与子宫内膜异位症[J]. 现代预防医学, 2018, 45(22): 4058-4061. https://www.cnki.com.cn/Article/CJFDTOTAL-XDYF201822008.htm
    [10]
    沈杨, 刘娟, 任慕兰, 等. 二噁英对小鼠异位子宫内膜影响的分子机制研究[J]. 中山大学学报: 医学科学版, 2010, 31(5): 608-613. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSYK201005007.htm
    [11]
    曹现岭, 孙振高. 子宫内膜异位症的遗传学发病机制研究进展[J]. 国际生殖健康/计划生育杂志, 2019, 38(1): 67-70, 82. doi: 10.3969/j.issn.1674-1889.2019.01.014
    [12]
    庞朋沙, 过倩萍, 伍会健, 等. 细胞内AhR信号转导通路的机制研究[J]. 现代生物医学进展, 2010, 10(13): 2567-2570. https://www.cnki.com.cn/Article/CJFDTOTAL-SWCX201013061.htm
    [13]
    Guo S W. The association of endometriosis risk and genetic polymorphisms involving dioxin detoxification enzymes: a systematic review[J]. Eur J Obstet Gynecol Reprod Biol, 2006, 124(2): 134-143. doi: 10.1016/j.ejogrb.2005.10.002
    [14]
    安晓汾, 杨丽萍, 刘淑娟, 等. CYP1A1基因多态性与吉林籍汉族女性子宫内膜异位症易感性的研究[J]. 中国妇幼保健, 2011, 26(14): 2174-2176. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201114042.htm
    [15]
    Matsuzaka Y, Kikuti Y Y, Goya K, et al. Lack of an association human dioxin detoxification gene polymorphisms with endometriosis in Japanese women: results of a pilot study[J]. Environ Health Prev Med, 2012, 17(6): 512-517. doi: 10.1007/s12199-012-0281-y
    [16]
    Juo S H, Wang T N, Lee J N, et al. CYP17, CYP1A1 and COMT polymorphisms and the risk of adenomyosis and endometriosis in Taiwanese women[J]. Hum Reprod, 2006, 21(6): 1498-1502. doi: 10.1093/humrep/del033
    [17]
    Babu K A, Reddy N G, Deendayal M, et al. GSTM1, GSTT1 and CYP1A1 detoxification gene polymorphisms and their relationship with advanced stages of endometriosis in South Indian women[J]. Pharmacogenet Genomics, 2005, 15(3): 167-172. doi: 10.1097/01213011-200503000-00005
    [18]
    王玉凤, 宗利丽, 赵欣, 等. 中国南方妇女AhR和ARNT基因多态性与子宫内膜异位症的相关性[J]. 中华医学遗传学杂志, 2011, 28(2): 195-198. doi: 10.3760/cma.j.issn.1003-9406.2011.02.016
    [19]
    杨丽萍, 安晓汾. 吉林市汉族妇女GSTM1基因和CYP1A1基因Exon7位点多态性与子宫内膜异位症易感性的研究[J]. 中国妇幼保健, 2009, 24(18): 2556-2559. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB200918039.htm
    [20]
    陈志芳, 丁岩, 林仁勇, 等. CYP1A1 MspI多态性及其合并GSTM1基因缺失与子宫内膜异位症的关系[J]. 现代妇产科进展, 2005, 14(4): 285-288. doi: 10.3969/j.issn.1004-7379.2005.04.007
    [21]
    Fan W, Huang Z Y, Xiao Z, et al. The cytochrome P4501A1 gene polymorphisms and endometriosis: a meta-analysis[J]. J Assist Reprod Genet, 2016, 33(10): 1373-1383. doi: 10.1007/s10815-016-0783-4
    [22]
    Wu C H, Guo C Y, Yang J G, et al. Polymorphisms of dioxin receptor complex components and detoxification-related genes jointly confer susceptibility to advanced-stage endometriosis in the taiwanese han population[J]. Am J Reprod Immunol, 2012, 67(2): 160-168. doi: 10.1111/j.1600-0897.2011.01077.x
    [23]
    任伟俏, 孙高高, 李晶, 等. 子宫内膜异位症患者血清CD38、缩宫素、白介素-1β表达情况及相关性研究[J]. 中国妇幼保健, 2019, 34(7): 1660-1663. https://www.cnki.com.cn/Article/CJFDTOTAL-ZFYB201907067.htm
    [24]
    温洁, 邓琳, 张信美, 等. 白细胞介素-1家族基因多态性与子宫内膜异位症的相关性研究[J]. 浙江大学学报: 医学版, 2006, 35(6): 653-657. doi: 10.3785/j.issn.1008-9292.2006.06.014
    [25]
    王志红, 赵虎, 袁博, 等. 子宫内膜异位症相关卵巢癌和卵巢子宫内膜异位症患者血清CA125和Smac水平比较[J]. 肿瘤基础与临床, 2019, 32(1): 18-20. doi: 10.3969/j.issn.1673-5412.2019.01.006
    [26]
    杨颖, 李华, 万红丽. 核酪蛋白激酶和细胞周期蛋白依赖性激酶底物在子宫内膜异位症相关卵巢癌中的表达及临床意义[J]. 中国计划生育和妇产科, 2018, 10(11): 35-39. doi: 10.3969/j.issn.1674-4020.2018.11.09
    [27]
    Dominici R, Malferrari G, Mariani C, et al. The Interleukin 1-beta exonic (+3953) polymorphism does not alter in vitro protein secretion[J]. Exp Mol Pathol, 2002, 73(2): 139-141. doi: 10.1006/exmp.2002.2435
    [28]
    钱欢欢, 戴辉华, 林明娟, 等. 子宫内膜异位症相关恶性肿瘤的研究进展[J]. 南京医科大学学报: 自然科学版, 2019, 39(3): 442-447. https://www.cnki.com.cn/Article/CJFDTOTAL-NJYK201903028.htm
    [29]
    汤桑桑, 沈源明, 万小云. 子宫内膜异位症相关卵巢癌发生机制的研究进展[J]. 现代妇产科进展, 2018, 27(10): 788-791. https://www.cnki.com.cn/Article/CJFDTOTAL-XDFC201810019.htm
  • Related Articles

    [1]ZHOU Hongyou, FU Dongming, LI Ran, WU Zhikai, HAN Hao, MENG Bin. Percutaneous vertebroplasty versus percutaneous kyphoplasty in treating Kummell disease of peripheral sclerosis type in stage Ⅲ[J]. Journal of Clinical Medicine in Practice, 2022, 26(4): 37-41. DOI: 10.7619/jcmp.20214960
    [2]MIAO Yiming, CHEN Jun, JIANG Xiaowei, XU Yue, LU Wei, WANG Qiang. Application of modified "eggshell" technology in osteoporotic vertebral compression fracture patients with percutaneous kyphoplasty[J]. Journal of Clinical Medicine in Practice, 2022, 26(2): 119-122, 127. DOI: 10.7619/jcmp.20211342
    [3]YANG Haihao, XIAO Rui. Effects of zoledronic acid in different time periods in the treatment of elderly osteoporotic vertebral compression fractures after percutaneous kyphoplasty[J]. Journal of Clinical Medicine in Practice, 2021, 25(12): 61-65, 69. DOI: 10.7619/jcmp.20210010
    [4]CHEN Jiaru, ZENG Sheng, XIAO Chao. Effects of different vertebroplasty on refracture of adjacent vertebral bodies in patients with osteoporotic vertebral fractures[J]. Journal of Clinical Medicine in Practice, 2021, 25(9): 29-31. DOI: 10.7619/jcmp.20210489
    [5]SUN Yijun, SUN Qing, GONG Futai. Effect of percutaneous kyphoplasty in the treatment of osteoporotic vertebral compression fractures[J]. Journal of Clinical Medicine in Practice, 2020, 24(23): 45-48. DOI: 10.7619/jcmp.202023015
    [6]WANG Yu, LU Yang, ZHANG Yuping. Effect of "5A" nursing in prevention of deep venous thrombosis of lower extremity after percutaneous kyphoplasty in patients with vertebral compression fractures[J]. Journal of Clinical Medicine in Practice, 2019, 23(22): 73-75. DOI: 10.7619/jcmp.201922025
    [7]XIANG Chunshan. Impact of pereutaneous vertebroplasty and percutaneous kyphoplasty on quality of life in old patients with osteoporoticthoracolumbar vertebral fractures[J]. Journal of Clinical Medicine in Practice, 2017, (23): 15-17. DOI: 10.7619/jcmp.201723005
    [8]WANG Chun, CHEN Jian, WANG Xiu, JIN Gang, ZHANG Beiguang, SUN Zhiqiang, YU Shilong. Application of 3D-CT in treatment of vertebral metastases by percutaneous vertebroplasty[J]. Journal of Clinical Medicine in Practice, 2014, (21): 49-51. DOI: 10.7619/jcmp.201421014
    [9]CUI Hong. Comparison betweeen unilateral and bilateral percutaneous kyphoplasty therapy in treating patients with osteoporotic vertebral compression fractures[J]. Journal of Clinical Medicine in Practice, 2014, (17): 63-65. DOI: 10.7619/jcmp.201417018
    [10]YU Zhongjie, WENG Yiping, ZHANG Yunkun. Clinical effect of over-extending reduction combined with percutaneous vertebroplasty on vertebral compression fractures caused by osteoporosis[J]. Journal of Clinical Medicine in Practice, 2013, (19): 24-26. DOI: 10.7619/jcmp.201319008

Catalog

    Article views (299) PDF downloads (5) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return